The All Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (APPG) has published its final report into botulinum toxin, dermal fillers and other aesthetic non-surgical cosmetic treatments today.
Aesthetic practitioner national register Save Face has issued a warning as new figures reveal a demand in cosmetic treatments is expected this summer.
Healthcare Improvement Scotland (HIS) has confirmed in a Stakeholder meeting earlier this week that aesthetic nurses who own HIS-registered clinics can now legally stock prescription only medications (POMs) such as botulinum toxin and hyaluronidase on premises.
Xeomin® has received cosmetic approval from the US Food and Drug Administration (FDA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
The British Association of Cosmetic Nurses (BACN) has released its view on the All Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (APPG) final report which was released on Wednesday.
The Australian government’s Therapeutic Goods Administration (TGA) has introduced new regulations preventing social media influencers being paid to endorse health, cosmetic and skincare goods (therapeutic goods).
Global pharmaceutical company Merz Aesthetics has launched an official Facebook page.
Pharmaceutical company Croma Pharma has submitted its botulinum toxin drug file to the German Federal Institute for Drugs and Medical Devices (BfArM), for approval for the treatment of glabellar lines in the EU.
Aesthetics training provider Cosmetic Courses has launched a new botulinum toxin training course.
A recent video on social media showing dermal filler being injected into the tear trough through the mouth has sparked concern among practitioners.